Latest court orders, judgments, and legal developments from Indian courts — AI-curated and summarized.
A recent analysis reflects on the limitations of India’s patent law provisions relying on Sections 92 and 100, highlighting the ongoing Ribociclib litigation as a critical case study. The emphasis is laid on the infrastructure challenges rather than merely legal impediments in improving access to patented medications.
Khaitan & Co has facilitated a Composite Scheme of Arrangement for the amalgamation of Woodlands Multispeciality Hospital and RPSG Ventures Limited.
The Kerala High Court has mandated that practitioners of electro-homeopathy must register under state laws, asserting that the practice cannot be viewed as unregulated.
The Central Drugs Standard Control Organization seeks feedback on brand name extensions by pharmaceutical companies. This marks a notable regulatory shift in oversight of pharmaceutical branding.
This article provides an overview of the regulations surrounding drug licensing in India, a critical component for pharmaceutical operations. It focuses on the necessary steps and legal requirements for obtaining a Drug License.
The Central Drugs Standard Control Organization (CDSCO) is inviting stakeholder comments on its policies regarding brand name extensions in the pharmaceutical sector. This move could lead to crucial changes in the practice of branding in the industry.
The Directorate General of Health Services has invited comments on the use of brand name extensions in pharma, potentially signaling regulatory changes that could affect marketing strategies of pharmaceutical companies.
DSK Legal provided legal advice to the Asian Institute of Medical Sciences on an exit strategy for its private equity investors, facilitating significant financial transitions.